Please login to the form below

Not currently logged in
Email:
Password:

EMD Serono appoints neurology and immunology SVP

Promotes head of US Fertility and Endocrinology Craig Millian

EMD Serono, the US-based biopharma business of Germany's Merck KGaA, has promoted Craig Millian to senior vice president of neurology and immunology.

Millian most recently served as senior vice president and head of US fertility and endocrinology at EMD Serono, having first joined in 2010.

Previously, he was vice president, commercial at Vertex and has held commercial leadership roles at Pfizer and Sanofi.

Gary Zieziula, president and managing director of EMD Serono, said: “Craig is a dynamic leader with a proven track record of success.

“He has been instrumental in expanding our leadership in fertility and endocrinology, and he will bring that passion and expertise to the neurology and immunology business, furthering our commitment to improve care for people living with multiple sclerosis and other conditions as we advance our pipeline.”

23rd September 2016

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics